Wound healing a multidisciplinary approach for dermatologists

Dermatologic Clinics

Volumn 21, Issue 2, 2003, Pages 371-387

  Mostow, Eliot N ^a,b,c  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; BISABOLOL; RETINOL; VITAMIN D; XIPAMIDE;

CLINICAL PRACTICE; CLINICAL PROTOCOL; DEBRIDEMENT; HUMAN; HYPERTHERMIC THERAPY; MEDICAL SPECIALIST; OINTMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMA; WOUND CARE; WOUND DRESSING; WOUND HEALING;

EID: 0038408992     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00100-6     Document Type: Review

References (117)

1. http://www.woundcarenet.com/ (Advances in Skin and Wound Care) or http://www.woundheal. org (Wound Healing Society) or http://www.wound caresymposiumcom.com/ (Symposium on Advanced Wound Care).
2. Krasner KD, Kane D, editors. Chronic wound care. A clinical source book for heathcare professionals. 2nd edition. Health Management Pubns; 1997.
3. Steed DL, Edington H, Moosa HH, Webster MW. Organization and development of a university multidisciplinary wound care clinic. Surgery 1993;114:775-8, discussion 778-9.
4. Gottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar T. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 2001;136:765-72.
5. Valdes A, Angderson C, Giner JJ. A multidisciplinary, therapy-based, team approach for efficient and effective wound healing: a retrospective study. Ostomy/Wound Management 1999;45:30-6.
6. Ratliff C, Rodeheaver G. The chronic wound care clinic: "one-stop shopping". J Wound Ostomy Continence Nurs 1995;22:77-80.
7. Levin M. Diabetic foot ulcers: pathogenesis and management. JET Nurs 1993;20:191-8.
8. Miller III OF. Essentials of pressure ulcer treatment. The diabetic experience. J Dermatol Surg Oncol 1993;19:759-63.
9. Allman RM, Laprade CA, Noel LB, Walker JM, Moorer CA, Dear MR, et al. Pressure sores among hospitalized patients. Ann Intern Med 1986;105:337-42.
10. Allman RM, Walker JM, Hart MK, Laprade CA, Noel LB, Smith CR. Air-fluidized beds or conventional therapy for pressure sores. A randomized trial. Ann Intern Med 1987;107:641-8.
11. Guralnik JM, Harris TB, White LR, CornoniHuntley JC. Occurrence and predictors of pressure sores in the National Health and Nutrition Examination survey follow-up. J Am Geriatr Soc 1988;36:807-12.
12. Powell JW. Increasing acuity of nursing home patients and the prevalence of pressure ulcers: a ten year comparison. Decubitus 1989;2:56-8.
13. Smith DM, Winsemius DK, Besdine RW. Pressure sores in the elderly: can this outcome be improved? J Gen Intern Med 1991;6:81-93.
14. Nelzen O, Bergqvist D, Lindhagen A, Hallbook T. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 1991;45:184-7.
15. Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg 1996;83:255-8.
16. US Census Bureau. Profile of general demographic characteristics for the United States: 2000 (Table DP-1). Washington, DC: U.S. Census Bureau; 2000.
17. Robinson PA, director. Field of Dreams. 1989.
18. Mostow E. Diagnosis and classification of chronic wounds. Clin Dermatol 1994;12:3-9.
19. Bon FX, et al. Quantitative and kinetic evolution of wound healing through image analysis. IEEE Trans Med Imaging 2000;19:767-72.
20. Zebrick G. Wound Imager 2.0. 1950 Old Cuthbert Road, Suite L, Cherry Hill, NJ 08034: Med-Data Systems, Inc.
21. Colletti P. Wound Expert. 336 Fourth Avenue Suite 602, Pittsburgh, PA 15222: Net Health Systems, Inc.
22. Bryant JL, Brooks TL, Schmidt B, Mostow EN. Reliability of wound measuring techniques in an outpatient wound center. Ostomy Wound Manage 2001;47:44-51.
23. Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. Journal of the American Academy of Dermatology 2000;43:627-30.
24. Stewart A, Leaper DJ. Treatment of chronic ulcers in the community: a comparison of Scherinsorb and lodosorb. Phlebology 1987;2:115-21.
25. Kikta MJ, Schuler JJ, Meyer JP, Durham JR, Eldrup-Jorgensen J, Schwarcz TH, et al. A prospective randomized trial of Unna's boots vs hydroactive dressings in the treatment of venous stasis ulcers. J Vasc Surg 1988;7:478-83.
26. Margolis DJ, Berlin JA, Strom BL. Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol 1999;135:920-6.
27. Kane D. Wound healing and wound management. In: Krasner D, editor. Chronic wound care. 2nd edition. Wayne (PA): Health Management Publications, Inc; 1997. p. 1-4.
28. Thakur N. Topical ointments and wound healing. J Fam Pract 1997;44:26-7.
29. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88:4-21.
30. Smack DP, Harrington AC, Dunn C, Howard RS, Szkutnik AJ, Krivda SJ, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA 1996;276:972-7.
31. Ellner KM, Goldberg LH, Sperber J. Comparison of cosmesis following healing by surgical closure and second intention. J Dermatol Surg Oncol 1987;13:1016-20.
32. Zitelli J. Wound healing by secondary intention. J Am Acad Dermatol 1983;9:407-15.
33. Kaye ET. Topical antibacterial agents. Infect Dis Clin N Am 2000;14:321-39.
34. Rietschel RL, Fowler JF, Fisher AA. Reactions to topical antimicrobials, Chapter 13. In: Rietschel RL, Fowler JF, Fisher AA, editors. Fisher's contact dermatitis. 4th edition. Baltimore (MD): Lippincott, Williams & Wilkins; 1995. p. 205-24.
35. Geronemus RG, Mertz PM, Eaglstein WH. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 1979;115:1311-4.
36. Eaglstein W. Moist wound healing with occlusive dressings: a clinical focus. Dermatol Surg 2001;27:175-81.
37. Siegel DM, Sun DK, Artman N. Surgical pearl: a novel cost-effective approach to wound closure and dressings. J Am Acad Dermatol 1996;34:673-5.
38. Margolis DJ, Berlin JA, Strom BL. Which venous leg ulcers will heal with limb compression bandages? Am J Med 2000;109:15-9.
39. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2000;(3):CD000265.
40. Jull AB, Waters J, Arroll B. Oral pentoxifylline for treatment of venous leg ulcers. J Tissue Viability 2000 Oct;10(4):161.
41. Partanen J, et al. Natural history of peripheral neuropathy in patients with non - insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
42. Sherwin R. Diabetes mellitus - part II. In: Goldman BJ, editor. Cecil textbook of medicine. Philadelphia (PA): WB Saunders; 2000. p. 1282-4.
43. Mayfield J, Sugarman J. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. Journal of Family Practice 2000;49:S17-29.
44. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract 2001;54:115-28.
45. Catanzariti A, Haverstock BD, Grossman JP, et al. Off-loading techniques in the treatment of diabetic plantar neuropathic foot ulceration. Adv Wound Care 1999;12:452-8.
46. Inlow S, Kalla T, Rahman J. Downloading plantar foot pressures in the diabetic patient. Ostomy/Wound Management 1999;45:28-38, quiz 39-40.
47. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000;16(Suppl 1): S75-83.
48. Maklebust J. An update on horizontal patient support surfaces. Ostomy/Wound Management 1999;45:70S-7S, quiz 78S-9S.
49. van Rijswijk L, Braden BJ. Pressure ulcer patient and wound assessment: an AHCPR clinical practice guideline update. Ostomy/Wound Management 1999;45:56S-67S,quiz 68S-9S.
50. Kantor J, Margolis D. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol 2000;142:960-4.
51. Nephew S.A. Smith & Nephew marketing a Westaim Biomadical product. 15 Adam Street, London WC2N 6LA UK: Smith & Nephew, Corporate HQ.
52. Medline Industries. 1 Medline Place, Mundelein, IL 60060: Medline Industries, Inc.
53. AcryMed. 12232 SW Garden Place, Portland, OR 92773: AcryMed.
54. Silveron. 4780 Mountain Road, Stowe, VT 05672: Silveron Consumer Products.
55. Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998;19:531-7.
56. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 1999;20:195-200.
57. Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 2001;27:621-7.
58. Prevel CD, Eppley BL, Summerlin DJ, Sidner R, Jackson JR, McCarty M, et al. Small intestinal submucosa: utilization as a wound dressing in fullthickness rodent wounds. Ann Plast Surg 1995;35:381-8.
59. Prevel CD, Eppley BL, Summerlin DJ, Sidner R, Jackson JR, McCarty M, et al. Small intestinal submucosa: utilization for repair of rodent abdominal wall defects. Ann Plast Surg 1995;35:374-80.
60. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997;67:478-91.
61. Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol 1998;25:812-7.
62. Kirsner RS. The use of Apligraf in acute wounds. J Dermatol 1998;25:805-11.
63. Trent JF, Kirsner RS. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract 1998;52:408-13.
64. Dolynchuk K, Hull P, Guenther L, Sibbald RG, Brassard A, Cooling M, et al. The role of Apligraf in the treatment of venous leg ulcers. Ostomy/Wound Management 1999;45:34-43.
65. Bello YM, Falabella AF, Eaglstein WH. Tissueengineered skin. Current status in wound healing. Am J Clin Dermatol 2001;2:305-13.
66. Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen 2000;8:251-7.
67. Nicholls H. FDA approves Dermagraft for diabetic foot ulcers. Trends Endocrinol Metab 2001;12:433.
68. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-4.
69. Edmonds ME, Foster AV, McColgan M. "Dermagraft": a new treatment for diabetic foot ulcers. Diabet Med 1997;14:1010-1.
70. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997;21:1203-10.
71. Bowering CK. Dermagraft in the treatment of diabetic foot ulcers. J Cutan Med Surg 1998;3(Suppl 1):S1-32.
72. Eaglstein WH. Dermagraft treatment of diabetic ulcers. J Dermatol 1998;25:803-4.
73. Grey JE, Lowe G, Bale S, Harding KG. The use of cultured dermis in the treatment of diabetic foot ulcers. J Wound Care 1998;7:324-5.
74. Williams C. The management of patients with venous leg ulcers: new guidelines. British Journal of Nursing 1999;8:489-95.
75. Vowden K, Vowden P. Wound debridement, part 2: sharp techniques. J Wound Care 1999;8:291-4.
76. Vowden KR, Vowden P. Wound debridement, part 1: non-sharp techniques. J Wound Care 1999;8:237-40.
77. Cervo F, Cruz A, Posillico J. Pressure ulcers. Analysis of guidelines for treatment and management. Geriatrics 2000;55:55-60, quiz 62.
78. Thomas D. Prevention and treatment of pressure ulcers: what works? What doesn't? Clev Clin J Med 2001;68:704-22.
79. Salcido R. Enzymatic debridement: a tried and tested method. Adv Skin Wound Care 2000 May-Jun;13 (3 Pt 1):92.
80. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. Journal of the American Academy of Dermatology 1998;39:737-40.
81. Sinclair RD, Ryan TJ. Proteolytic enzymes in wound healing: the role of enzymatic debridement. Australas J Dermatol 1994;35:35-41.
82. Smith LW. The present status of topical chlorophyll therapy. New York J Med 1955;55:2041.
83. Kennedy KL, Tritch DL. Debridement. In: Krasner KD, editor. Chronic wound care. 2nd edition. Wayne (PA): Health Management Publications; 1997. p. 227-34.
84. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999;38:623-7.
85. Thomas S, Andrews A, Jones M, Church J. Maggots are useful in treating infected or necrotic wounds. Brit Med J (Clinical Research Edition) 1999;318:807-8.
86. Wollina U, Karte K, Herold C, Looks A. Biosurgery in wound healing - the renaissance of maggot therapy. Journal of the European Academy of Dermatology and Venereology 2000;14:285-9.
87. Sherman RA, Pechter EA. Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis. Med Vet Entomol 1988;2:225-30.
88. Sherman RA, My-Tien Tran JM. A simple, sterile food source for rearing the larvae of Lucilia sericata (Diptera: Calliphoridae). Med Vet Entomol 1995;9:393-8.
89. Stoddard SR, Sherman RA, Mason BE, Pelsang DJ, Sherman RM. Maggot debridement therapy. An alternative treatment for nonhealing ulcers. J Am Podiatr Med Assoc 1995;85:218-21.
90. Sherman RA, Tran JM, Sullivan R. Maggot therapy for venous stasis ulcers. Arch Dermatol 1996;132:254-6.
91. Sherman RA, Wyle FA. Low-cost, low-maintenance rearing of maggots in hospitals, clinics, and schools. Am J Trop Med Hyg 1996;54:38-41.
92. Sherman RA. A new dressing design for use with maggot therapy. Plast Reconstr Surg 1997;100:451-6.
93. Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000;45:55-81.
94. Sherman RA, Sherman J, Gilead L, Lipo M, Mumcuoglu KY. Maggot debridement therapy in outpatients. Arch Phys Med Rehabil 2001;82:1226-9.
95. Sherman RA. Maggot therapy project home page. http://www.ucihs.uci.edu/com/pathology/sherman/home_pg.htm.
96. Scott EM, Leaper DJ, Clark M, Kelly PJ. Effects of warming therapy on pressure ulcers - a randomized trial. AORN Journal 2001;73:921-38.
97. Kloth LC, Berman JE, Dumit-Minkel S, Sutton CH, Papanek PE, Wurzel J. Effects of a normothermic dressing on pressure ulcer healing. Adv Skin Wound Care 2000;13:69-74.
98. Santilli SM, Valusek PA, Robinson C. Use of a noncontact radiant heat bandage for the treatment of chronic venous stasis ulcers. Adv Wound Care 1999;12:89-93.
99. Morykwas MJ, Argenta LC, Shelton-Brown El, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553-62.
100. Hartnett JM. Use of vacuum-assisted wound closure in three chronic wounds. J Wound Ostomy Continence Nurs 1998;25:281-90.
101. Evans D, Land L. Topical negative pressure for treating chronic wounds: a systematic review. Brit J Plast Surg 2001;54:238-42.
102. Hersh RE, Kaza AK, Long SM, Fiser SM, Drake DB, Tribble CG. A technique for the treatment of sternal infections using the vacuum assisted closure device. Heart Surg Forum 2001;4:211-5.
103. DeFranzo AJ, Argenta LC, Marks MW, Molnar JA, David LR, Webb LX, et al. The use of vacuumassisted closure therapy for the treatment of lowerextremity wounds with exposed bone. Plast Reconstr Surg 2001;108:1184-91.
104. Brown KM, Harper FV, Aston WJ, O'Keefe PA, Cameron CR. Vacuum-assisted closure in the treatment of a 9-year-old child with severe and multiple dog bite injuries of the thorax. Ann Thorac Surg 2001;72:1409-10.
105. Gwan-Nulla DN, Casal RS. Toxic shock syndrome associated with the use of the vacuum-assisted closure device. Ann Plast Surg 2001;47:552-4.
106. Prutkin L. Wound healing and vitamin A acid. Acta Derm Venereol 1972;52:489-92.
107. Tumberello J. Using vitamin A&D ointment for wounds. Oncol Nurs Forum 1995 Jul;22(6):989.
108. Terkelsen LH, Eskild-Jensen A, Kjeldsen H, Barker JH, Hjortdal VE. Topical application of cod liver oil ointment accelerates wound healing: an experimental study in wounds in the ears of hairless mice. Scand J Plast Reconstr Surg Hand Surg 2000;34:15-20.
109. Umezawa Y, Oyake S, Oh-i T, Nagae T, Ishimaru S. A case of pyoderma gangrenosum on the stump of an amputated right leg. J Dermatol 2000;27:529-32.
110. Blitz NM, Rudikoff D. Pyoderma gangrenosum. Mt Sinai J Med 2001;68:287-97.
111. Wines N, Wines M, Ryman W. Review article understanding pyoderma gangrenosum: a review. MedGenMed 2001 Jun 27;3(3):6.
112. Mokni M, Phillips TJ. Management of pyoderma gangrenosum. Hosp Pract (Office Edition) 2001;36:40-4.
113. Lyon CC, Stapleton M, Smith AJ, Griffiths CE, Beck MH. Topical sucralfate in the management of peristomal skin disease: an open study. Clin Exp Dermatol 2000;25:584-8.
114. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000;135:564-8, discussion 568-9.
115. Warner BW. Peristomal pyoderma gangrenosum. Gastroenterology 2000;119:873-4.
116. Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 2000;284:1546-8.
117. Frykberg R. Epidemiology of the diabetic foot: ulcerations and amputations. Advances in Wound Care 1999;12:139-41.